Givaudan Active Beauty has launched Neuroglow, an active skin care ingredient designed to safely replicate the positive effects of the sun.
Neuroglow mimics the beneficial properties of sunlight, stimulating production of melanin (+126%) and promoting the skin’s release of wellbeing molecules such as beta-endorphin (+43%), vitamin D (+345%) and oxytocin (+229%).
By boosting melanin production, it prepares the skin for sun exposure, allowing for a faster, healthier, more natural and better protected tan.
As well as boosting vitamin D production, sunlight is recognised for its positive impact on mood and energy while contributing to a healthy appearance thanks to its desirable tanning effects.
The results from the first clinical trial demonstrated a remarkable phototype shift in 76% of participants in seven days, moving from phototype II to phototype III, and of these, 40% even shifted to a darker phototype IV, compared to 0% in the placebo group.
In a second clinical trial involving volunteers experiencing seasonal mood changes due to lack of sunlight, Neuroglow reduced tiredness, increased feelings of affection, and improved ‘winter blues’, with over 80% of volunteers reporting a positive score.
Crafted by Green Fractionation from Persicaria tinctoria (Japanese indigo), the ingredient is sourced from Provence in France.
“Our scientists in R&D Green Fractionation have identified and optimised a plant-derived active ingredient offering an unprecedented solution to mimic all the positive effects of sunlight,” said Givaudan R&D Green Fractionation manager Bénédicte Sennelier-Portet.
“The result? A healthy glow and enhanced wellbeing all year round, even when combined with SPF, highlighting the benefits of the sun,” she added.
